Advertisements

Stocking Stuffers

 

Aequus Pharmaceuticals Inc. (AQS:CA) Stock Quote

Detailed Quote for Aequus Pharmaceuticals Inc. (AQS:CA)
$ 0.20   0.005 (+2.56%) Volume: 174.71k 3:57 PM EST Feb 22, 2019
Today 5d 1m 3m 1y more
Last Price
0.20
Change $
0.005
Change %
2.56%
Tick
  
Bid
0.20
Bid Size
23,000
Ask
0.205
Ask Size
2,500
Open
0.20
High
0.21
Low
0.20
Prev Close
0.195
Last Trade
02/22/19
Volume
174.71k
52 Wk Hi
0.335000008
52 Wk Low
0.129999995
Market Cap
16.23m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
81,136,970
EPS (TTM)
-0.039999999
PE Ratio
N/A
Exchange
TSXV
News and Media for Aequus Pharmaceuticals Inc. (AQS:CA)
Sector News | Topic News
News for Aequus Pharmaceuticals Inc. (AQS:CA)
Mon, Dec 17, 2018
8:30 AM Aequus Signs Term Sheet with European Partner for a Preservative Free Therapeutic in Ophthalmology - GlobeNewswire
Thu, Nov 29, 2018
6:15 PM Aequus Reports Largest Quarterly Revenue in Company History and Provides Management Update - GlobeNewswire
Thu, Nov 15, 2018
8:45 AM Aequus Strengthens Clinical Experience on Strategic Advisory Board in Ophthalmology, and Adds Commercial and Regulatory Expertise - GlobeNewswire
Tue, Nov 13, 2018
8:45 AM Aequus Hosts Live Webinar Demonstrating the Zepto\u00AE Capsulotomy System, Led by Dr. Ike Ahmed - GlobeNewswire
Mon, Nov 05, 2018
8:45 AM Aequus forms Strategic Advisory Board in Ophthalmology, Chaired by Dr. Ike Ahmed - GlobeNewswire
Mon, Aug 27, 2018
8:45 AM Aequus Reports 5th Consecutive Quarter of Revenue Growth - GlobeNewswire
Fri, Aug 10, 2018
8:45 AM Aequus Closes Balance of $775,000 Equity Financing - GlobeNewswire
Thu, Aug 09, 2018
8:45 AM Aequus Announces Fully-subscribed $775,000 Equity Financing - GlobeNewswire
Tue, Jul 31, 2018
8:45 AM Aequus Announces Closing of $800,000 Equity Financing - GlobeNewswire
Tue, Jul 24, 2018
6:00 PM Issuance of Stock Options - GlobeNewswire
Mon, Jul 23, 2018
8:45 AM Aequus Announces Proposed $800,000 Equity Financing To Next Edge Biotech Plus Fund - GlobeNewswire
Thu, Jul 19, 2018
8:45 AM Aequus Announces Expansion of Market Opportunity for its Long Acting Anti-Nausea Transdermal Patch - GlobeNewswire
Mon, Jul 16, 2018
8:45 AM Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada - GlobeNewswire
Fri, Jul 13, 2018
8:45 AM Aequus Announces New Independent Director to its Board - GlobeNewswire
Thu, Jun 21, 2018
8:45 AM Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch - GlobeNewswire
Mon, Jun 18, 2018
8:45 AM Aequus Announces First Canadian Cataract Procedures Using Zepto Capsulotomy System - GlobeNewswire
Thu, May 31, 2018
8:45 AM Aequus Provides First Quarter 2018 Financial and Corporate Highlights - GlobeNewswire
Wed, May 16, 2018
8:45 AM Aequus Announces Official Launch of Zepto Capsulotomy System in Canada to be June 1, 2018 - GlobeNewswire
Thu, May 03, 2018
8:50 AM Biotech Industry Presses Forward with Latest Transdermal Drug Delivery Advancements - MarketNewsUpdates
8:45 AM Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch - GlobeNewswire
More News for AQS:CA >>

Tags for Aequus Pharmaceuticals Inc.

Research stocks or mutual funds related to Aequus Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to AQS:CA. The keywords below have been associated to AQS:CA by either user submission or electronic means.